Referências bibliográficas

• [1] NOMURA, Hidetaka et al. Maintenance hormonal therapy after treatment with medroxyprogesterone acetate for patients with atypical polypoid adenomyoma. Japanese Journal Of Clinical Oncology, [s.l.], v. 48, n. 3, p.255-258, 17 jan. 2018. Oxford University Press (OUP). http://dx.doi.org/10.1093/jjco/hyx193.

• [2] DITTO, Antonino et al. Long-term safety of fertility sparing surgery in early stage ovarian cancer: Comparison to standard radical surgical procedures. Gynecologic Oncology, [s.l.], v. 138, n. 1, p.78-82, jul. 2015. Elsevier BV. http://dx.doi.org/10.1016/j.ygyno.2015.05.004.

• [3]

• [4] 3. HELPMAN, Limor et al. Safety of ovarian conservation and fertility preservation in advanced borderline ovarian tumors. Fertility And Sterility, [s.l.], v. 104, n. 1, p.138-144, jul. 2015. Elsevier BV. ttp://dx.doi.org/10.1016/j.fertnstert.2015.03.038

• [5] 4. SOUZA, Elen et al. Preservação da fertilidade e dos ovários em mulheres com tumores anexiais benignos. Revista Brasileira de Ginecologia e Obstetrícia, [s.l.], v. 37,

• [6] n. 1, p.36-41, jan. 2015. FapUNIFESP (SciELO). ttp://dx.doi.org/10.1590/so100-720320140005179.

• [7] 5. LYU, Jiangtao; SUN, Tingting; TAN, Xianjie. Ovarian Preservation in Young Patients With Stage I Cervical Adenocarcinoma. International Journal Of Gynecological Cancer, [s.l.], v. 24, n. 8, p.1513-1520, out. 2014. Ovid Technologies (Wolters Kluwer Health). http://dx.doi.org/10.1097/igc.0000000000000231.

• [8] 6. HENES, Melanie et al. Possibilities of Fertility Preservation in Young Patients with Ovarian Cancer. Anticancer Research, Abu Dhabi, Emirados Árabes, v. 34, n. 7, p.3851-3854, maio 2014.

• [9] 7. WANG, Chin-jung et al. Fertility-Preserving Treatment in Young Women With Endometrial Adenocarcinoma. International Journal Of Gynecological Cancer, [s.l.], v. 24, n. 4, p.718-728, maio 2014. Ovid Technologies (Wolters Kluwer Health). ttp://dx.doi.org/10.1097/igc.0000000000000098.

• [10] 8. FAKHR, Ibrahim et al. Outcome of fertility preserving surgery in early stage ovarian cancer. Journal Of The Egyptian National Cancer Institute, [s.l.], v. 25, n. 4, p.219-222, dez. 2013. Elsevier BV. ttp://dx.doi.org/1016/j.jnci.2013.07.003.

• [11] 9. PARLAKGUMUS, Huriye Ayse et al. Fertility outcomes of patients with early stage endometrial carcinoma. Journal Of Obstetrics And Gynaecology Research, [s.l.], v. 40, n. 1, p.102-108, 5 set. 2013. Wiley. ttp://dx.doi.org/10.1111/jog.12132.

• [12] 10. SUN, Chaoyang et al. Safety of ovarian preservation in young patients with early-stage endometrial cancer: a retrospective study and meta-analysis. Fertility And Sterility, [s.l.], v. 100, n. 3, p.782-787, set. 2013. Elsevier BV. ttp://dx.doi.org/10.1016/j.fertnstert.2013.05.032.

• [13] 11. FANG, Liu et al. [A retrospective study of tumor and fertility outcomes after fertility-sparing surgical treatment of patients with borderline ovarian tumors]. Jornal Médico Chinês, China, v. 97, n. 47, p.3699-3703, dez. 2017.

• [14] 12. NASIOUDIS, Dimitrios et al. Fertility-preserving surgery for advanced stage ovarian germ cell tumors. Gynecologic Oncology, [s.l.], v. 147, n. 3, p.493-496, dez. 2017. Elsevier BV. http://dx.doi.org/10.1016/j.ygyno.2017.10.010.

• [15] 13. NASIOUDIS, Dimitrios et al. Safety of Fertility-Sparing Surgery for Premenopausal Women With Sex Cord-Stromal Tumors Confined to the Ovary. International Journal Of Gynecological Cancer, [s.l.], v. 27, n. 9, p.1826-1832, nov.

• [16]

• [17] 20 Ovid Technologies (Wolters Kluwer Health). http://dx.doi.org/10.1097/igc.0000000000001110.

• [18] 14. WANG, Fangfang et al. Fertility Preserved Hysteroscopic Approach for the Treatment of Stage Ia Endometrioid Carcinoma. International Journal Of Gynecological Cancer, [s.l.], v. 27, n. 9, p.1919-1925, nov. 2017. Ovid Technologies (Wolters Kluwer Health). http://dx.doi.org/10.1097/igc.0000000000001109.

• [19] 15. HELPMAN, Limor et al. Fertility preservation in women with borderline ovarian tumors - how does it impact disease outcome? A cohort study. Acta Obstetricia Et Gynecologica Scandinavica, [s.l.], v. 96, n. 11, p.1300-1306, 21 set. 2017. Wiley. ttp://dx.doi.org/10.1111/aogs.13203.

• [20] 16. JIANG, Xuan et al. Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age. World Journal Of Surgical Oncology, [s.l.], v. 15, n. 1, p.1-11, 15 ago. 2017. Springer Nature. http://dx.doi.org/10.1186/s12957-017-1222-4.

• [21] 17. NASIOUDIS, imitrios et al. Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma? Journal Of Gynecologic Oncology, [s.l.], v. 28, n. 6, p.1-10, 2017. Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy (KAMJE). ttp://dx.doi.org/10.3802/jgo.2017.28.e71.

• [22] 18. PLANTE, Marie et al. Simple Vaginal Trachelectomy. International Journal Of Gynecological Cancer, [s.l.], v. 27, n. 5, p.1021-1027, jun. 2017. Ovid Technologies (Wolters Kluwer Health). http://dx.doi.org/10.1097/igc.0000000000000989.

• [23] 19. LEE, Young-jae et al. Feasibility of uterine preservation in the management of early-stage uterine adenosarcomas: a single institute experience. World Journal Of Surgical Oncology, [s.l.], v. 15, n. 1, p.1-5, 19 abr. 2017. Springer Nature. http://dx.doi.org/10.1186/s12957-017-1137-0.

• [24] 20. HOU, Ting et al. The Safety of Ovarian Preservation in Stage I Endometrial Endometrioid Adenocarcinoma Based on Propensity Score Matching. Combinatorial Chemistry & High Throughput Screening, [s.l.], v. 20, n. 7, 23 out. 2017. Bentham Science Publishers Ltd.. http://dx.doi.org/10.2174/1386207320666170417145856.

• [25] 21. PARK, Jeong-yeol et al. Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors. Gynecologic Oncology, [s.l.], v. 145, n. 3, p.513-518, jun. 2017. Elsevier BV. http://dx.doi.org/10.1016/j.ygyno.2017.03.023.

• [26] 22. TURKMEN, Osman et al. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors. Journal Of Adolescent And Young Adult Oncology, [s.l.], v. 6, n. 2, p.270-276, jun. 2017. Mary Ann Liebert Inc. http://dx.doi.org/10.1089/jayao.2016.0086.

• [27]

• [28] 23. GREENWALD, Zoë R. et al. Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer? Cancer, [s.l.], v. 123, n. 9, p.1545-1554, 27 dez. 2016. Wiley. http://dx.doi.org/10.1002/cncr.30529.

• [29] 24. XIE, Weimin et al. Fertility-sparing surgery for patients with low-grade endometrial stromal sarcoma. Oncotarget, [s.l.], v. 8, n. 6, 6 out. 2016. Impact Journals, LLC. http://dx.doi.org/10.18632/oncotarget.12491.

• [30] 25. FRUSCIO, Robert et al. Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer. British Journal Of Cancer, [s.l.], v. 115, n. 6, p.641-648, 18 ago. 2016. Springer Nature. ttp://dx.doi.org/10.1038/bjc.2016.254.

• [31] 26. VANCRAEYNEST, Eveline et al. Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors. International Journal Of Gynecological Cancer, [s.l.], v. 26, n. 8, p.1399-1406, out. 2016. Ovid Technologies (Wolters Kluwer Health). http://dx.doi.org/10.1097/igc.0000000000000782.

• [32] 27. PARK, Jeong-yeol et al. Outcomes of fertility-sparing surgery among young women with FIGO stage I clear cell carcinoma of the ovary. International Journal Of Gynecology & Obstetrics, [s.l.], v. 134, n. 1, p.49-52, 11 mar. 2016. Wiley. http://dx.doi.org/10.1016/j.ijgo.2015.10.022.

• [33] 28. GHEZZI, Fabio et al. Laparoscopic fertility-sparing surgery for early ovarian epithelial cancer: A multi-institutional experience. Gynecologic Oncology, [s.l.], v. 141, n. 3, p.461-465, jun. 2016. Elsevier BV. http://dx.doi.org/10.1016/j.ygyno.2016.03.030.

• [34] 29. CHEN, Rui-fang et al. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience. Journal Of Ovarian Research, [s.l.], v. 9, n. 1, 18 mar. 2016. Springer Nature. ttp://dx.doi.org/10.1186/s13048-016-0226-y.

• [35] 30. PARK, Jin-young et al. Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer. Journal Of Gynecologic Oncology, [s.l.],

• [36] v. 27, n. 2, p.1-10, 2016. Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy (KAMJE). http://dx.doi.org/10.3802/jgo.2016.27.e20.

• [37] 31. BASTA, P et al. [Fertility-sparing surgical management of ovarian cancer]. Ginekol, Polônia, v. 86, n. 10, p.759-764, out. 2015.

• [38] 32. WRIGHT, Jason D. et al. Utilization and Outcomes of Ovarian Conservation in Premenopausal Women With Endometrial Cancer. Obstetrics & Gynecology, [s.l.], v. 127, n. 1, p.101-108, jan. 2016. Ovid Technologies (Wolters Kluwer Health). ttp://dx.doi.org/10.1097/aog.0000000000001181.

• [39]

• [40] 33. GONTHIER, C et al. Cancer Incidence in Patients with Atypical Endometrial Hyperplasia Managed by Primary Hysterectomy or Fertility-sparing Treatment. Anticancer Res, França, v. 12, n. 35, p.6799-6804, dez. 2015.

• [41] 34. NOMURA, Hidetaka et al. Long-term outcomes of fertility-sparing treatment of atypical polypoid adenomyoma with medroxyprogesterone cetate. Archives Of Gynecology And Obstetrics, [s.l.], v. 293, n. 1, p.177-181, 26 jul. 2015. Springer Nature. http://dx.doi.org/10.1007/s00404-015-3824-9.